Identification of an Immune Gene Expression Signature for Predicting Lung Squamous Cell Carcinoma Prognosis

Table 1

Patient characteristics with lung squamous cell carcinoma in training and testing sets.

Clinical features	Overall	Training set	Testing set	value
OS	493	245	248	0.9383
Event	493	245	248	0.9293
Alive	284	140	144
Dead	209	105	104
T	493	245	248	0.4717
T1	114	49	65
T2	286	146	140
T3	70	40	30
T4	23	10	13
N	493	242	246	0.7437
N0	316	160	156
N1	127	62	65
N2	40	19	21
N3	5	1	4
NX	5	3	2
M	493	208	204	0.6093
M0	405	206	199
M1	7	2	5
MX	81	37	44
Stage	493	244	245	0.4364
I	241	116	125
II	158	88	70
III	83	38	45
IV	7	2	5
X	4	1	3
Age	493	245	248	0.6387
0~50	22	9	13
50~60	73	40	33
60~70	181	85	96
70~80	191	97	94
80~100	26	14	12
Subdivision	493	235	240	0.8473
Bronchial	10	5	5
L-Lower	74	33	41
L-Upper	135	68	67
R-Lower	106	52	54
R-Middle	18	10	8
R-Upper	132	67	65
Gender	493	245	248	0.9648
Female	128	63	65
Male	365	182	183